The coronary artery disease paradox

American Journal of Hypertension

Volumn 9, Issue 4 SUPPL. 2, 1996, Pages 2S-10S

  Black, Henry R ^a,b  

^a RUSH MEDICAL COLLEGE   (United States)

^b Department of Preventive Medicine ^*  (United States)

Author keywords

Blood pressure; Circadian rhythm; Coronary artery disease; Dippers; Hypertension; Nondippers

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMILORIDE; ANGIOTENSIN ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCHLOROTHIAZIDE; METOPROLOL; PROPRANOLOL; THIAZIDE DIURETIC AGENT; VASODILATOR AGENT;

AGED; CIRCADIAN RHYTHM; CONFERENCE PAPER; CORONARY ARTERY DISEASE; HUMAN; HYPERTENSION; PRIORITY JOURNAL;

ANTIHYPERTENSIVE AGENTS; CLINICAL TRIALS; CORONARY DISEASE; HUMANS; HYPERTENSION; RISK FACTORS;

EID: 0029983272     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/08957-0619(50)04025-     Document Type: Article

References (66)

1. Harington M, Kincaid-Smith P, McMichael J: Results of treatment in malignant hypertension: A seven year experience in 94 cases. Br Med J 1959;2:969-980.
2. White PD: Heart Disease, 2nd ed. New York, Macmillan, 1937, p 326.
3. Pooling Project Research Group: Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the Pooling Project. J Chron Dis 1978;31:201-306.
4. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension. JAMA 1967;202:1028-1034.
5. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension. JAMA 1970;213:1143-1152.
6. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993;153:154-183.
7. Perry HM, for the Veterans Administration-National Heart, Lung, and Blood Institute Study Group for Cooperative Studies on Antihypertensive Therapy, Mild Hypertension: Treatment of mild hypertension: preliminary results of a two-year feasibility trial. Circ Res 1977;40(suppl I):I-180-I-187.
8. Hypertension Detection and Follow-up Program Cooperative Group: Five-year findings of the Hypertension Detection and Follow-up Program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 1979;242:2562-2571.
9. Helgeland A: Treatment of mild hypertension: a five-year controlled drug trial. The Oslo Study. Am J Med 1980;69:725-732.
10. Australian National Blood Pressure Management Committee: The Australian therapeutic trial in mild hypertension. Lancet 1980;i:1261-1267.
11. Medical Research Council Working Party: MRC trial of treatment of mild hypertension: principal results. Br Med J 1985;291:97-104.
12. Smith WM, for the US Public Health Service Hospitals Cooperative Study Group: Treatment of mild hypertension: results of a ten-year intervention trial. Circ Res 1977;40:98-105.
13. Hypertension-Stroke Cooperative Study Group: Effect of antihypertensive treatment on stroke recurrence. JAMA 1974;229:409-418.
14. Wolff FW, Lindeman RD: Effects of treatment in hypertension: results of a controlled study. J Chron Dis 1966;19:227-240.
15. Barraclough M, Bainton D, Cochrane AL, et al: Control of moderately raised blood pressure: Report of a cooperative randomized controlled trial. Br Med J 1973;3:434-436.
16. Carter AB: Hypotensive therapy in stroke survivors. Lancet 1970;i:485-489.
17. Amery A, Birkenhäger W, Brixko P, et al: Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1985;i:1349-1354.
18. Coope J, Warrender TS: Randomised trial of treatment of hypertension in elderly patients in primary care. Br Med J 1986;293:1145-1151.
19. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-3264.
20. Dahlöf B, Lindholm LH, Hansson L, et al: Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991;338: 1281-1285.
21. MRC Working Party: Medical Research Council trial of treatment of hypertension in older adults: Principal results. Br Med J 1992;304:405-412.
22. Hypertension Detention and Follow-up Program Cooperative Group: Five-year findings of the Hypertension Detection and Follow-up Program. II. Mortality by race, sex and age. JAMA 1979;242:2572-2577.
23. Sagie A, Larson MG, Levy D: The natural history of borderline isolated systolic hypertension. N Engl J Med 1993;329:1912-1917.
24. Neaton JD, Grimm RH, Jr., Prineas RJ, et al: Treatment of Mild Hypertension Study. Final Results. JAMA 1993;270:713-724.
25. Collins R, Peto R, MacMahon S, et al: Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomised drug trial in their epidemiological context. Lancet 1990;335:827-838.
26. MacMahon S, Peto R, Cutler J, et al: Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-774.
27. MacMahon S, Rodgers A: The effects of antihypertensive treatment of vascular disease: reappraisal of the evidence in 1994. J Vasc Med Biol 1993;4:265-271.
28. Black HR: The coronary artery disease paradox: the role of hyperinsulinemia and insulin resistance and implications for therapy. J Cardiovasc Pharmacol 1990; 15(suppl 5):S26-S38.
29. Langford HG, Stamler J, Wassertheil-Smoller S, Prineas RJ: All-cause mortality in the hypertension detection and follow-up program: findings for the whole cohort and for persons with less severe hypertension, with and without other traits related to risk of mortality. Prog Cardiovasc Dis 1986;29:29-54.
30. Neaton JD, Wentworth D, for the Multiple Risk Factor Intervention Trial Research Group: Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease: overall findings and differences by age for 316,099 white men. Arch Intern Med 1992; 152:56-64.
31. Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee: 1993 Guidelines for the management of mild hypertension: Memorandum from a World Health Organization/International Society of Hypertension Meeting. Hypertension 1993;22: 392-403.
32. Alderman MH: Blood pressure management: individualized treatment based on absolute risk and the potential for benefit. Ann Intern Med 1993;119:329-335.
33. Mulrow CD, Cornell JA, Herrera CR, et al: Hypertension in the elderly: implications and generalizability of randomized trials. JAMA 1994;272:1932-1938.
34. Kannel WB, Gordon T, Schwartz MJ: Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham Study. Am J Cardiol 1971; 27:335-346.
35. Madhavan S, Ooi WL, Cohen H, Alderman MH: Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension 1994;23:395-401.
36. Sutton-Tyrrell K, Alcorn HG, Wolfson SK, et al: Predictors of carotid stenosis in older adults with and without isolated systolic hypertension. Stroke 1993;24: 355-361.
37. Sleight P: Blood pressures, hearts, and U-shaped curves (letter). Lancet 1988;i:235.
38. Burt VL, Whelton P, Roccella EJ, et al: Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;25:305-313.
39. White WB: Assessment of patients with office hypertension by 24-hour noninvasive ambulatory blood pressure monitoring. Arch Intern Med 1986:146:2196-2199.
40. Julius S, Jamerson K, Mejia A, et al: The association of borderline hypertension with target organ changes and higher coronary risk. Tecumseh Blood Pressure Study. JAMA 1990;264:354-358.
41. Weber MA, Neutel JM, Smith DHG, Graettinger WF: Diagnosis of mild hypertension by ambulatory blood pressure monitoring. Circulation 1994:90:2291-2298.
42. Verdecchia P, Porcellati C, Schillaci G, et al: Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension 1994;24: 793-801.
43. Verdecchia P, Schillaci G, Guerrieri M, et al: Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990;81:528-536.
44. Lipid Research Clinics Program: The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA 1984;3:251:351-364.
45. Buchwald H, Varco RL, Matts JP, et al: Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia: report of the Program on the Surgical Control of the Hyperlipidemias (POSCH). N Engl J Med 1990;323:946-955.
46. Scandinavian Simvastatin Survival Study Group: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389.
47. Black HR: Metabolic considerations in the choice of therapy for the patient with hypertension. Am Heart J 1991;121:707-715.
48. Kasiske BL, Ma JZ, Kalil RSN, Louis TA: Effects of antihypertensive therapy on serum lipids. Ann Intern Med 1995;122:133-141.
49. Leary WP, Reyes AJ, Van Der Byl K: Effects of a combination of hydrochlorothiazide and amiloride on urinary magnesium excretion in healthy adults. Curr Ther Res 1984;35:293-300.
50. Reaven GM: Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
51. Pollare T, Lithell H, Berne C: A comparison of the effects of hydrochlorothiazide and captropril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 1989;321:868-873.
52. Lind L, Pollare T, Berne C, Lithell H: Long-term metabolic effects of antihypertensive drugs. Am Heart J 1994;128:1177-1183.
53. Stewart IM: Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension. Lancet 1979;i:861-865.
54. Cruickshank JM, Thorp JM, Zacharias FJ: Benefits and potential harm of lowering high blood pressure. Lancet 1987;i:581-583.
55. D'Agostino RB, Belanger AJ, Kannel W, Cruickshank JM: Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: The Framigham study. Br Med J 1991;303:385-389.
56. Farnett L, Mulrow CD, Linn WD, Lucey CR, Tuley MR: The J-curve phenomenon and the treatment of hypertension: is there a point beyond which pressure reduction is dangerous? JAMA 1991;265:489-495.
57. Davis BR, Cutler JA, Gordon DJ, et al: Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). (in press).
58. The HOT Study Group: The Hypertension Optimal Treatment Study (The HOT Study). Blood Pressure 1993;2:62-68.
59. Davis BR, Ford CE, Remington RD, et al: The Hypertension Detection and Follow-up Program: design, methods, and baseline characteristics and blood pressure response of the study population. Prog Cardiovasc Dis 1986;29(suppl 1):11-28.
60. Muller JE, Stone PH, Turi ZG, et al: Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985;313:1315-1322.
61. Muller JE, Ludmer PL, Willich SN, et al: Circadian variation in the frequency of sudden cardiac death. Circulation 1987;75:131-138.
62. Millar-Craig MW, Bishop CN, Raftery EB: Circadian variation of blood-pressure. Lancet 1978;i:795-797.
63. Rocco MB, Barry J, Campbell S, et al: Circadian variation of transient myocardial ischemia in patients with coronary artery disease. Circulation 1987;75:395-400.
64. Davies MJ, Thomas AC: Plaque fissuring - the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 1985;53:363-373.
65. Andreotti F, Davies GJ, Hackett DR, et al: Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke. Am J Cardiol 1988;62: 635-637.
66. White WB, Anders RJ, MacIntyre JM, et al and the Verapamil Study Group: Nocturnal dosing of a novel delivery system of verapamil for systemic hypertension. Am J Cardiol 1995;76:375-380.